News|Articles|January 2, 2005

Pharmaceutical Technology

  • Pharmaceutical Technology-01-02-2005
  • Volume 29
  • Issue 1

Patheon Places Big Bet with Mova Acquisition

Author(s)Jim Miller

Patheon is betting the whole is worth more than the sum of the parts in its acquisition of Puerto Rico contract manufacturer Mova.


Related to this article

CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 1
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.